122 related articles for article (PubMed ID: 32767951)
21. Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis.
Zhang L; Chen Y; Wang K
Curr Probl Cancer; 2019 Apr; 43(2):135-144. PubMed ID: 30017407
[TBL] [Abstract][Full Text] [Related]
22. Serum human epididymis protein 4 concentrations are associated with severity of patients with pulmonary tuberculosis.
Li L; Yao Y; Liang J; Zhan X; Wang F; Yue C; Wu BQ; Hu S; Liu M; Wan J; Luo J
Clin Chim Acta; 2020 Mar; 502():255-260. PubMed ID: 31730821
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of serum human epididymis protein 4 in liver fibrosis: An experimental study.
Hou Y; Li F; Chen J; Zhao J; Li D; Chen H
Medicine (Baltimore); 2020 Nov; 99(48):e23428. PubMed ID: 33235124
[TBL] [Abstract][Full Text] [Related]
24. Elevated human epididymis protein 4 concentrations in chronic kidney disease.
Nagy B; Krasznai ZT; Balla H; Csobán M; Antal-Szalmás P; Hernádi Z; Kappelmayer J
Ann Clin Biochem; 2012 Jul; 49(Pt 4):377-80. PubMed ID: 22688735
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
Dewan R; Dewan A; Jindal M; Bhardawaj M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
[TBL] [Abstract][Full Text] [Related]
26. Cystatin C provides a better estimate of the effect of glomerular filtration rate on serum human epididymis protein 4 concentrations.
Ferraro S; Pasqualetti S; Carnevale A; Panteghini M
Clin Chem Lab Med; 2016 Oct; 54(10):1629-34. PubMed ID: 27092650
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.
Wan J; Wang Y; Cai G; Liang J; Yue C; Wang F; Song J; Wang J; Liu M; Luo J; Li L
Oncotarget; 2016 Oct; 7(42):67748-67759. PubMed ID: 27589683
[TBL] [Abstract][Full Text] [Related]
28. Urinary Human Epididymis Secretory Protein 4 as a Useful Biomarker for Subclinical Acute Rejection Three Months after Kidney Transplantation.
Tajima S; Fu R; Shigematsu T; Noguchi H; Kaku K; Tsuchimoto A; Okabe Y; Masuda S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546745
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic performances of CA125, HE4, and ROMA index in ovarian cancer.
Dikmen ZG; Colak A; Dogan P; Tuncer S; Akbiyik F
Eur J Gynaecol Oncol; 2015; 36(4):457-62. PubMed ID: 26390703
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of human epididymis protein 4 in malignant pleural effusion in lung cancer.
Lv M; Wang F; Wang X; Zhang C
Cancer Biomark; 2019; 26(4):523-528. PubMed ID: 31658049
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta-analysis.
Olsen M; Lof P; Stiekema A; van den Broek D; Wilthagen EA; Bossuyt PM; Lok CAR
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1788-1799. PubMed ID: 34212386
[TBL] [Abstract][Full Text] [Related]
32. Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.
Bandiera E; Romani C; Specchia C; Zanotti L; Galli C; Ruggeri G; Tognon G; Bignotti E; Tassi RA; Odicino F; Caimi L; Sartori E; Santin AD; Pecorelli S; Ravaggi A
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2496-506. PubMed ID: 22028406
[TBL] [Abstract][Full Text] [Related]
33. Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
Espiau Romera A; Coronado Martín PJ; Chóliz Ezquerro M; Cuesta Guardiola T; Adiego Calvo I; Baquedano Mainar L
Int J Gynaecol Obstet; 2021 Apr; 153(1):64-70. PubMed ID: 33156532
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women.
Yu S; Lee JK; Kim JH; Park H; Lee MY; Ryu S; Kwon MJ; Woo HY
Gynecol Oncol; 2016 Oct; 143(1):128-134. PubMed ID: 27426308
[TBL] [Abstract][Full Text] [Related]
35. Role of Human Epididymis Protein 4 (HE4) in Determining Survival of Patients With Endometrial Cancer: A Meta-Analysis.
He Y; Wang J; Ma CX; Kang YH
Technol Cancer Res Treat; 2020; 19():1533033820971660. PubMed ID: 33148127
[TBL] [Abstract][Full Text] [Related]
36. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer.
Nagy B; Bhattoa HP; Steiber Z; Csobán M; Szilasi M; Méhes G; Müller M; Lázár J; Kappelmayer J; Antal-Szalmás P
Clin Chem Lab Med; 2014 Nov; 52(11):1639-48. PubMed ID: 24829194
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic performance of HE4 and ROMA among Chinese women.
Shen Y; Zhao L; Lu S
Clin Chim Acta; 2020 Jan; 500():42-46. PubMed ID: 31626761
[TBL] [Abstract][Full Text] [Related]
38. Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance.
Yuan J; Duan R; Yang H; Luo X; Xi M
Int J Nanomedicine; 2012; 7():2921-8. PubMed ID: 22745553
[TBL] [Abstract][Full Text] [Related]
39. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
40. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
Escudero JM; Auge JM; Filella X; Torne A; Pahisa J; Molina R
Clin Chem; 2011 Nov; 57(11):1534-44. PubMed ID: 21933899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
